Mozobil — Class III drug recall D-1518-2016
Terminated recall by Genzyme Corporation / Genzyme Biosurgery, reported 2016-09-28, distributed nationwide. Labeling: Incorrect or Missing Lot and/or Exp. Date
| Recall number | D-1518-2016 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Genzyme Corporation / Genzyme Biosurgery, Ridgefield, NJ, United States |
| Recall initiated | 2016-08-04 |
| Classified | 2016-09-22 |
| Reported by FDA | 2016-09-28 |
| Terminated | 2018-04-19 |
| Distributed | Nationwide (US) |
| Quantity | 9,530 vials |
| Reason classes | labeling |
| NDC | 00024-5862, 00024-5862-01 |
| Lot numbers | 04/18, 5RZ002 |
Product
Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp. Date
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1518-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.